From reprogrammed stem cells to next-generation gene editing, 2024 has seen some incredible developments with the potential to become new treatments.

"This financing represents a significant milestone for the company and signals strong support of the potential of HERVs to tackle pressing challenges in cancer, metabolic disease and aging," said ...

The potential for TL1A-targeting duvakitug to impact unmet needs of patients with ulcerative colitis (UC) and Crohn’s disease (CD), and to provide anti-fibrotic effects for a host of other diseases, ...

Gene therapy for haemophilia A using Roctavian and lentivirus vector shows promise in treating the rare, hereditary condition ...

New artificial intelligence tools help scientists fight back against a rising tide of research misconduct, but is it enough?

The T cells are activated with cytokines to stimulate cell division, and a viral vector is then used to engineer the cells to express a chimeric ... and is evaluating allogeneic CD19 CAR-T for ...

AgriLife Research is working on a new research project to combat the zebra chip disease, which has impacted potato production for decades.

Full Circles Therapeutics ("Full Circles"), a leader in next-generation cell and gene therapies, today announced the publication of a groundbreaking study in Nature Biotechnology. The paper, titled ...

This article explores the latest techniques and workflows for purification across biopharmaceuticals including vaccines, ...

ESO-T01 is the first in vivo BCMA CAR-T candidate to reach the clinical stage MONT-SAINT-GUIBERT, Belgium, Dec. 11, 2024 (GLOBE NEWSWIRE) -- EsoBiotec SA, a biotechnology company empowering cells in ...

Median OS increased from 11 to 13 months in IMNN-001 treatment group based on latest data analysis No change in IMNN-001 favorable safety profile including no reports of serious immune-related adverse ...